GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

Selincro image

Lundbeck’s alcohol pill given NICE approval

November 27, 2014
Sales and Marketing Lundbeck, NHS, NICE, alcohol, selincro

NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …

Soliris image

NHS to get world’s most expensive drug

November 27, 2014
Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris

UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS).  Soliris …

NHS image

NHS needs £2 billion more in funding

November 26, 2014
Medical Communications, Sales and Marketing Cameron, Hunt, Kings Fund, NHS, Osborne, king's fund, statement

Healthcare think tank the King’s Fund has called for an additional £2 billion to be injected into the NHS in …

UK lags behind in healthcare outcomes index

November 26, 2014
Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes

Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …

mike_ohara

Sharp Packaging Services hires MD

November 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mike O’Hara, Sharp Packaging Services

Sharp Packaging Services that is a part of UDG Healthcare has announced that Mike O’Hara has joined the firm as …

Kofi Annan speaks at the 'global crisis of depression' summit hosted in Lo

Mental and physical health should be treated equally

November 26, 2014
Medical Communications, Research and Development, Sales and Marketing Campbell, Lundbeck, depression, kofi annan, wiinberg

The need for a new approach to depression that gives it equal importance to physical health was the focus of …

Cell Medica image

Cell Medica gets £50 million funding

November 26, 2014
Research and Development, Sales and Marketing CMD-003, Cancer, Imperial Innovations, Invesco Perpetual, Woodford Investment Management, celk medica

Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …

Priority review for Novartis myeloma drug

November 26, 2014
Sales and Marketing FDA, Farydak, Novartis, daratumumab, elotuzumab, myeloma, odac

Novartis’ multiple myeloma treatment Farydak has been given an extended review by the FDA after its future seemed in jeopardy …

paul_workman

Institute of Cancer Research names chief executive

November 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICR, Institute of Cancer Research, paul workman

Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …

Biomarin image

BioMarin to buy Prosensa in $840 million deal

November 25, 2014
Sales and Marketing BioMarin, Prosensa, drisapersen, dystrophy

Rare-disease drug firm BioMarin has finalised its purchase of muscular disease specialist Prosensa in a deal worth over $840 million. …

Ulf Wiinberg image

Lundbeck chief executive resigns amid scandal

November 25, 2014
Medical Communications, Sales and Marketing Björklund, Lundbeck, stratified medical, ulf wiinberg

Ulf Wiinberg has resigned from his chief executive post at Denmark-based pharma giant Lundbeck following a beach of its rules …

natasha_weeks

Virgo Consumer Health promotes to senior team

November 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo, natasha weeks, rebecca rhodes

Virgo has promoted its long-standing employee Natasha Weeks (pictured) to the position of director and lead of its Consumer Health …

BI image

CHMP nods several drugs through

November 24, 2014
Sales and Marketing Boehringer, CHMP, EMA, Esbriet, FDA, Sanofi, nintedanib, ofev

Ten new medicines have been recommended for approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP), among …

Ebola image

Takeda: we’re working on Ebola too

November 24, 2014
Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

Antibiotics image

Antibiotics: will the industry saviour please stand up

November 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, EAA, MRC, WHO, resistance, susie lunt

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

alberto_martinez_napp

New managing director for Napp Pharmaceuticals

November 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Napp, alberto, martinez

Alberto Martinez has joined Napp Pharmaceuticals in the UK as its new managing director, taking over the role from Dietmar …

ABPI image

ABPI: NHS must change to allow stratified drugs

November 21, 2014
Research and Development, Sales and Marketing ABPI, NHS, george freeman, personalised, rawal, stratified medicines

The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …

Future bleak for Novartis’ myeloma drug

November 21, 2014
Medical Communications FDA, Farydak, Novartis, ixazomib, myeloma, panobinostat

Novartis suffered a major disappointment with the negative FDA panel vote for multiple myeloma candidate Farydak earlier this month, but …

johan_halen_ablynx

Ablynx looks to GSK for new chief commercial officer

November 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, johan heylan

Belgium-based biopharma firm Ablynx has appointed Johan Heylen to be its chief commercial officer and assume responsibility for all commercial …

The Gateway to Local Adoption Series

Latest content